What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Disease
- Immune system
His main research concerns Atopic dermatitis, Dermatology, Immunology, Atopy and Allergy.
The study incorporates disciplines such as Epidemiology, Adverse effect and Disease in addition to Atopic dermatitis.
His research in Dermatology intersects with topics in Body surface area, SCORAD, Guideline, Randomized controlled trial and Cohort.
He interconnects Phosphodiesterase and Internal medicine, Endocrinology, Histamine in the investigation of issues within Immunology.
His Atopy research includes elements of Irritation, Abnormal skin and Eczema herpeticum.
His Allergy course of study focuses on Immunopathology and Risk factor, Genetic variation, Thymic stromal lymphopoietin and Genetic variants.
His most cited work include:
- Diagnostic features of atopic dermatitis (3091 citations)
- Guidelines for the Diagnosis and Management of Food Allergy in the United States: Summary of the NIAID-Sponsored Expert Panel Report (1693 citations)
- Duration of antiviral immunity after smallpox vaccination (702 citations)
What are the main themes of his work throughout his whole career to date?
His primary scientific interests are in Atopic dermatitis, Dermatology, Immunology, Allergy and Atopy.
His Atopic dermatitis research is mostly focused on the topic Eczema Area and Severity Index.
His Dermatology research includes themes of Randomized controlled trial, Surgery, Allergic contact dermatitis and Asthma.
He has included themes like Endocrinology, Histamine and Virology in his Immunology study.
Jon M. Hanifin studies Food allergy, a branch of Allergy.
Jon M. Hanifin has researched Internal medicine in several fields, including Gastroenterology, Placebo and Phosphodiesterase.
He most often published in these fields:
- Atopic dermatitis (60.82%)
- Dermatology (40.21%)
- Immunology (35.40%)
What were the highlights of his more recent work (between 2011-2021)?
- Atopic dermatitis (60.82%)
- Dermatology (40.21%)
- Immunology (35.40%)
In recent papers he was focusing on the following fields of study:
Jon M. Hanifin spends much of his time researching Atopic dermatitis, Dermatology, Immunology, Eczema herpeticum and Pediatrics.
His studies deal with areas such as Adverse effect and Randomized controlled trial as well as Atopic dermatitis.
In general Adverse effect study, his work on Tolerability often relates to the realm of Nemolizumab, thereby connecting several areas of interest.
His work focuses on many connections between Dermatology and other disciplines, such as Guideline, that overlap with his field of interest in Evidence-based medicine, SCORAD and Cyclosporin a.
His Immunology research integrates issues from Disease severity and Virology.
His Eczema Area and Severity Index research incorporates elements of Dermatology Life Quality Index and Severity of illness.
Between 2011 and 2021, his most popular works were:
- Guidelines of care for the management of atopic dermatitis: Section 2. Management and treatment of atopic dermatitis with topical therapies (517 citations)
- Guidelines of care for the management of atopic dermatitis: section 1. Diagnosis and assessment of atopic dermatitis. (500 citations)
- Emollient enhancement of the skin barrier from birth offers effective atopic dermatitis prevention (411 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Disease
- Immune system
Jon M. Hanifin mainly investigates Atopic dermatitis, Dermatology, Eczema Area and Severity Index, Randomized controlled trial and Adverse effect.
His Atopic dermatitis study is related to the wider topic of Immunology.
His Dermatology study combines topics from a wide range of disciplines, such as Guideline, Allergic contact dermatitis, Sex organ and Comorbidity.
The various areas that Jon M. Hanifin examines in his Eczema Area and Severity Index study include Dermatology Life Quality Index and Surgery.
His Randomized controlled trial research incorporates themes from Intervention, Relative risk and Incidence, Cumulative incidence.
His Adverse effect research includes elements of Erythema and Psychiatry.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
